The role of chemokines in B cell chronic lymphocytic leukaemia: Pathophysiological aspects and clinical impact

Annals of Hematology

Volumn 89, Issue 5, 2010, Pages 437-446

  Schröttner, Percy ^a   Leick, Marion ^a   Burger, Meike ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

B cell chronic lymphocytic leukaemia (B CLL); Chemokines; Clinical impact; Pathophysiology

Indexed keywords

BETA 2 MICROGLOBULIN; CASPASE 3; CASPASE 8; CD5 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROTEIN KINASE ZAP 70; STROMAL CELL DERIVED FACTOR 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR;

APOPTOSIS; B CELL LEUKEMIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL SURVIVAL; DOWN REGULATION; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; MACROPHAGE; MAST CELL; MONOCYTE; NEUTROPHIL; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; UPREGULATION; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; CELL MOTION; CHRONIC LYMPHATIC LEUKEMIA; CLASSIFICATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL MOVEMENT; CHEMOKINES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE ACTIVATION; RECEPTORS, CHEMOKINE;

EID: 77950550858     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0876-6     Document Type: Review

References (82)

1. PM Murphy M Baggiolini IF Charo CA Hebert R Horuk K Matsushima LH Miller JJ Oppenheim CA Power 2000 International union of pharmacology. XXII. Nomenclature for chemokine receptors Pharmacol Rev 52 145 176 1:CAS:528:DC%2BD3cXjvVWgtbs%3D 10699158
2. F Balkwill 2004 Cancer and the chemokine network Nat Rev Cancer 4 540 550 10.1038/nrc1388 1:CAS:528:DC%2BD2cXlt1Oktrs%3D 15229479
3. D Raman PJ Baugher YM Thu A Richmond 2007 Role of chemokines in tumor growth Cancer Lett 256 137 165 10.1016/j.canlet.2007.05.013 1:CAS:528: DC%2BD2sXhtVOisLrE 17629396 (Pubitemid 47418345)
4. HE Broxmeyer 2008 Chemokines in hematopoiesis Curr Opin Hematol 15 49 58 10.1097/MOH.0b013e3282f29012 1:CAS:528:DC%2BD1cXnvFWlsA%3D%3D 18043246 (Pubitemid 350191028)
5. V Pistoia A Corcione F Dallegri L Ottonello 2006 Lymphoproliferative disorders and chemokines Curr Drug Targets 7 81 90 10.2174/138945006775270187 1:CAS:528:DC%2BD28XitlOkug%3D%3D 16454701
6. ST Pals DJ de Gorter M Spaargaren 2007 Lymphoma dissemination: the other face of lymphocyte homing Blood 110 3102 3111 10.1182/blood-2007-05-075176 1:CAS:528:DC%2BD2sXht1yqur%2FK 17656647 (Pubitemid 350106300)
7. JA Burger A Burkle 2007 The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target Br J Haematol 137 288 296 10.1111/j.1365-2141.2007.06590.x 1:CAS:528: DC%2BD2sXntVSntLs%3D 17456052 (Pubitemid 46650259)
8. TJ Kipps 2000 Chronic lymphocytic leukemia Curr Opin Hematol 7 223 234 10.1097/00062752-200007000-00005 1:STN:280:DC%2BD3M%2FjtVGmug%3D%3D 10882178 (Pubitemid 30387846)
9. N Chiorazzi KR Rai M Ferrarini 2005 Chronic lymphocytic leukemia N Engl J Med 352 804 815 10.1056/NEJMra041720 1:CAS:528:DC%2BD2MXhsFCiu74%3D 15728813 (Pubitemid 40271175)
10. M Burger T Hartmann M Krome J Rawluk H Tamamura N Fujii TJ Kipps JA Burger 2005 Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells Blood 106 1824 1830 10.1182/blood-2004-12- 4918 1:CAS:528:DC%2BD2MXps1Ogt7g%3D 15905192 (Pubitemid 41208600)
11. I Binsky M Haran D Starlets Y Gore F Lantner N Harpaz L Leng DM Goldenberg L Shvidel A Berrebi R Bucala I Shachar 2007 IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival Proc Natl Acad Sci U S A 104 13408 13413 10.1073/pnas.0701553104 1:CAS:528:DC%2BD2sXps1Kgtb4%3D 17686984 (Pubitemid 47293958)
12. + B cells from patients with B cell lineage acute and chronic lymphocytic leukemia Cell Mol Immunol 1 280 294 1:CAS:528:DC%2BD2cXovFyjs7s%3D 16225771
13. M Alfonso-Perez S Lopez-Giral NE Quintana J Loscertales P Martin-Jimenez C Munoz 2006 Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia J Leukoc Biol 79 1157 1165 10.1189/jlb.1105623 1:CAS:528:DC%2BD28XlvVeruro%3D 16603585 (Pubitemid 44835549)
14. F Morabito RA Merendino G Penna M Cuzzola C Stelitano V Callea G Di Pasquale PL Minciullo S Gangemi 2005 The CX3C chemokine fractalkine (CX3CL1) is detectable in serum of B cell chronic lymphocytic leukemia patients with lymph node involvement Acta Haematol 113 152 154 10.1159/000083456 1:STN:280:DC%2BD2M7mvF2gug%3D%3D 15802897 (Pubitemid 40522822)
15. IM Ghobrial ND Bone MJ Stenson A Novak KE Hedin NE Kay SM Ansell 2004 Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma Mayo Clin Proc 79 318 325 10.4065/79.3.318 1:CAS:528:DC%2BD2cXitlOktLY%3D 15008605
16. E Ocana L Delgado-Perez A Campos-Caro J Munoz A Paz R Franco JA Brieva 2007 The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells Haematologica 92 349 356 10.3324/haematol.10649 17339184 (Pubitemid 350143544)
17. IO Kara B Sahin R Gunesacar 2007 Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis Adv Ther 24 29 40 10.1007/BF02849990 1:CAS:528:DC%2BD2sXlvFCktbw%3D 17526459
18. D Jones RJ Benjamin A Shahsafaei DM Dorfman 2000 The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia Blood 95 627 632 1:CAS:528:DC%2BD3cXlsFGhug%3D%3D 10627472
19. K Tachibana S Hirota H Iizasa H Yoshida K Kawabata Y Kataoka Y Kitamura K Matsushima N Yoshida S Nishikawa T Kishimoto T Nagasawa 1998 The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract Nature 393 591 594 10.1038/31261 1:CAS:528:DyaK1cXjvV2rurg%3D 9634237 (Pubitemid 28319250)
20. YR Zou AH Kottmann M Kuroda I Taniuchi DR Littman 1998 Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development Nature 393 595 599 10.1038/31269 1:CAS:528:DyaK1cXjvV2qsr4%3D 9634238 (Pubitemid 28319251)
21. Q Ma D Jones PR Borghesani RA Segal T Nagasawa T Kishimoto RT Bronson TA Springer 1998 Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice Proc Natl Acad Sci U S A 95 9448 9453 10.1073/pnas.95.16.9448 1:CAS:528:DyaK1cXltlCls74%3D 9689100 (Pubitemid 28506251)
22. JA Burger TJ Kipps 2002 Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells Leuk Lymphoma 43 461 466 10.1080/10428190290011921 1:CAS:528:DC%2BD38XntVartrk%3D 12002747 (Pubitemid 34232911)
23. JA Burger M Burger TJ Kipps 1999 Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells Blood 94 3658 3667 1:CAS:528: DyaK1MXnslykt70%3D 10572077
24. R Mohle C Failenschmid F Bautz L Kanz 1999 Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1) Leukemia 13 1954 1959 10.1038/sj/leu/2401602 1:CAS:528:DC%2BD3cXls1Onsw%3D%3D 10602415
25. JA Burger N Tsukada M Burger NJ Zvaifler M Dell'Aquila TJ Kipps 2000 Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1 Blood 96 2655 2663 1:CAS:528:DC%2BD3cXnt12gsLo%3D 11023495
26. J Durig U Schmucker U Duhrsen 2001 Differential expression of chemokine receptors in B cell malignancies Leukemia 15 752 756 10.1038/sj.leu.2402107 1:CAS:528:DC%2BD3MXks1Kks70%3D 11368435 (Pubitemid 32492698)
27. Z Zeng IJ Samudio M Munsell J An Z Huang E Estey M Andreeff M Konopleva 2006 Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias Mol Cancer Ther 5 3113 3121 10.1158/1535-7163.MCT-06-0228 1:CAS:528:DC%2BD28XhtlagsbrE 17172414 (Pubitemid 46092053)
28. + cells from non-Hodgkin's lymphoma. Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data Bone Marrow Transplant 41 331 338 10.1038/sj.bmt.1705908 1:CAS:528:DC%2BD1cXisVKiuro%3D 17994119 (Pubitemid 351330727)
29. D Wong W Korz 2008 Translating an antagonist of chemokine receptor CXCR4: from bench to bedside Clin Cancer Res 14 7975 7980 10.1158/1078-0432.CCR-07- 4846 1:CAS:528:DC%2BD1cXhsV2it73J 19088012
30. JA Burger A Peled 2009 CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers Leukemia 23 43 52 10.1038/leu.2008.299 1:CAS:528:DC%2BD1MXkvVarug%3D%3D 18987663
31. H Tsutsumi T Tanaka N Ohashi H Masuno H Tamamura K Hiramatsu T Araki S Ueda S Oishi N Fujii 2007 Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents Biopolymers 88 279 289 10.1002/bip.20653 1:CAS:528:DC%2BD2sXksVWltbw%3D 17167792 (Pubitemid 46661507)
32. F Bennett A Rawstron M Plummer R de Tute P Moreton A Jack P Hillmen 2007 B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle Br J Haematol 139 600 604 10.1111/j.1365-2141.2007.06790.x 17979945 (Pubitemid 350043808)
33. J Redondo-Munoz E Escobar-Diaz R Samaniego MJ Terol JA Garcia-Marco A Garcia-Pardo 2006 MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration Blood 108 3143 3151 10.1182/blood-2006-03-007294 1:CAS:528:DC%2BD28XhtFygtrbM 16840734
34. J Barretina J Junca A Llano A Gutierrez A Flores J Blanco B Clotet JA Este 2003 CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease Ann Hematol 82 500 505 10.1007/s00277-003-0679-0 1:CAS:528:DC%2BD3sXmtFGgtrc%3D 12783211 (Pubitemid 37062749)
35. LP Dao-Ung R Sluyter SJ Fuller J Taper JS Wiley 2004 CXCR4 but not CXCR3 expression correlates with lymphocyte counts in B-cell chronic lymphocytic leukemia Ann Hematol 83 326 327 10.1007/s00277-004-0846-y 14986066 (Pubitemid 38594335)
36. SJ Richardson C Matthews MA Catherwood HD Alexander BS Carey J Farrugia A Gardiner S Mould D Oscier JA Copplestone AG Prentice 2006 ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL) Blood 107 3584 3592 10.1182/blood-2005-04-1718 1:CAS:528:DC%2BD28Xkt1Gitbk%3D 16332969
37. PF di Celle A Carbone D Marchis D Zhou S Sozzani S Zupo M Pini A Mantovani R Foa 1994 Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein Blood 84 220 228 7517209
38. FP di Celle S Mariani L Riera A Stacchini G Reato R Foa 1996 Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion Blood 87 4382 4389
39. P Secchiero F Corallini E Barbarotto E Melloni MG di Iasio M Tiribelli G Zauli 2006 Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells J Cell Physiol 207 158 164 10.1002/jcp.20547 1:CAS:528:DC%2BD28XisFOjs7s%3D 16270354
40. P Secchiero MG di Iasio A Gonelli E Barbarotto E Melloni M Tiribelli C Chiaruttini G Zauli 2007 Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 J Cell Physiol 213 229 236 10.1002/jcp.21116 1:CAS:528:DC%2BD2sXhtVehtLnN 17476690 (Pubitemid 47378811)
41. R Horuk 2009 Chemokine receptor antagonists: overcoming developmental hurdles Nat Rev Drug Discov 8 23 33 10.1038/nrd2734 1:CAS:528:DC%2BD1MXpt12j 19079127
42. X Zhao F Li JR Town X Zhang W Wang JR Gordon 2007 Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology Int Immunopharmacol 7 1723 1731 10.1016/j.intimp.2007.09.008 1:CAS:528:DC%2BD2sXht12nsrfJ 17996682 (Pubitemid 350054930)
43. W Gonsiorek X Fan D Hesk J Fossetta H Qiu J Jakway M Billah M Dwyer J Chao G Deno A Taveras DJ Lundell RW Hipkin 2007 Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist J Pharmacol Exp Ther 322 477 485 10.1124/jpet.106.118927 1:CAS:528:DC%2BD2sXoslSjt7s%3D 17496166 (Pubitemid 47105793)
44. RW Chapman M Minnicozzi CS Celly JE Phillips TT Kung RW Hipkin X Fan D Rindgen G Deno R Bond W Gonsiorek MM Billah JS Fine JA Hey 2007 A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation J Pharmacol Exp Ther 322 486 493 10.1124/jpet.106.119040 1:CAS:528:DC%2BD2sXoslSjt7g%3D 17496165 (Pubitemid 47105794)
45. J Busch-Petersen 2006 Small molecule antagonists of the CXCR2 and CXCR1 chemokine receptors as therapeutic agents for the treatment of inflammatory diseases Curr Top Med Chem 6 1345 1352 1:CAS:528:DC%2BD28Xps1Sltr0%3D 16918453
46. A Parfienczyk B Kiersnowska-Rogowska F Rogowski 2003 Cytokine and adhesion molecule concentrations in blood of patients with B-cell chronic lymphocytic leukaemia with regard to disease progression Rocz Akad Med Bialymst 48 90 94 1:CAS:528:DC%2BD2cXitFCnug%3D%3D 14737950
47. WG Wierda MM Johnson KA Do T Manshouri A Dey S O'Brien FJ Giles H Kantarjian D Thomas S Faderl S Lerner M Keating M Albitar 2003 Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia Br J Haematol 120 452 456 10.1046/j.1365-2141.2003.04118.x 12580959 (Pubitemid 36241501)
48. S Molica G Vitelli D Levato L Levato A Dattilo GM Gandolfo 1999 Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia Haematologica 84 208 211 1:CAS:528:DC%2BD3cXlslSluw%3D%3D 10189383
49. L Ohl G Henning S Krautwald M Lipp S Hardtke G Bernhardt O Pabst R Forster 2003 Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs J Exp Med 197 1199 1204 10.1084/jem.20030169 1:CAS:528:DC%2BD3sXjs1ygsLs%3D 12732661 (Pubitemid 36570075)
50. G Muller UE Hopken M Lipp 2003 The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity Immunol Rev 195 117 135 10.1034/j.1600-065X.2003.00073.x 12969315 (Pubitemid 37153458)
51. K Reif EH Ekland L Ohl H Nakano M Lipp R Forster JG Cyster 2002 Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position Nature 416 94 99 10.1038/416094a 11882900 (Pubitemid 34215407)
52. A Burkle M Niedermeier A Schmitt-Graff WG Wierda MJ Keating JA Burger 2007 Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia Blood 110 3316 3325 10.1182/blood-2007-05- 089409 17652619 (Pubitemid 350106325)
53. JG Cyster 1999 Chemokines and cell migration in secondary lymphoid organs Science 286 2098 2102 10.1126/science.286.5447.2098 1:CAS:528: DyaK1MXotFGlsLY%3D 10617422
54. S Lopez-Giral NE Quintana M Cabrerizo M Alfonso-Perez M Sala-Valdes VG De Soria JM Fernandez-Ranada E Fernandez-Ruiz C Munoz 2004 Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination J Leukoc Biol 76 462 471 10.1189/jlb.1203652 1:CAS:528:DC%2BD2cXmtlKrsb4%3D 15155773 (Pubitemid 39006961)
55. + B cells J Immunol 177 6713 6722 17082584
56. M Ticchioni M Essafi PY Jeandel F Davi JP Cassuto M Deckert A Bernard 2007 Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a Oncogene 26 7081 7091 10.1038/sj.onc.1210519 1:CAS:528:DC%2BD2sXht1eqs7jO 17496928 (Pubitemid 350064189)
57. K Willimann DF Legler M Loetscher RS Roos MB Delgado I Clark-Lewis M Baggiolini B Moser 1998 The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7 Eur J Immunol 28 2025 2034 10.1002/(SICI)1521-4141(199806)28:06<2025::AID- IMMU2025>3.0.CO;2-C 1:CAS:528:DyaK1cXjsleit70%3D 9645384 (Pubitemid 28271719)
58. R Burgstahler B Kempkes K Steube M Lipp 1995 Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2 Biochem Biophys Res Commun 215 737 743 10.1006/bbrc.1995.2525 1:CAS:528:DyaK2MXos1Knt7w%3D 7488016
59. M Birkenbach K Josefsen R Yalamanchili G Lenoir E Kieff 1993 Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors J Virol 67 2209 2220 1:CAS:528:DyaK3sXisVyqtbk%3D 8383238
60. KJ Till K Lin M Zuzel JC Cawley 2002 The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes Blood 99 2977 2984 10.1182/blood.V99.8.2977 1:CAS:528:DC%2BD38XivV2js7s%3D 11929789 (Pubitemid 34525388)
61. H Gary-Gouy A Sainz-Perez JB Marteau A Marfaing-Koka J Delic H Merle-Beral P Galanaud A Dalloul 2007 Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype J Immunol 179 4335 4344 1:CAS:528:DC%2BD2sXhtVCrtbvM 17878328
62. S Qin JB Rottman P Myers N Kassam M Weinblatt M Loetscher AE Koch B Moser CR Mackay 1998 The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 746 754 10.1172/JCI1422 1:CAS:528:DyaK1cXht1Wrsbk%3D 9466968
63. L Trentin C Agostini M Facco F Piazza A Perin M Siviero C Gurrieri S Galvan F Adami R Zambello G Semenzato 1999 The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis J Clin Invest 104 115 121 10.1172/JCI7335 1:CAS:528:DyaK1MXktlOgsb0%3D 10393705
64. E Lazzeri P Romagnani 2005 CXCR3-binding chemokines: novel multifunctional therapeutic targets Curr Drug Targets Immune Endocr Metabol Disord 5 109 118 10.2174/1568008053174723 1:CAS:528:DC%2BD2MXisVKktLc%3D 15777209 (Pubitemid 40394308)
65. M Wijtmans D Verzijl R Leurs IJ de Esch MJ Smit 2008 Towards small-molecule CXCR3 ligands with clinical potential ChemMedChem 3 861 872 10.1002/cmdc.200700365 1:CAS:528:DC%2BD1cXnvVWmt7w%3D 18442035
66. EJ van Wanrooij SC de Jager T van Es P de Vos HL Birch DA Owen RJ Watson EA Biessen GA Chapman TJ van Berkel J Kuiper 2008 CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 28 251 257 10.1161/ATVBAHA.107.147827 18048768 (Pubitemid 351161196)
67. TC Walser S Rifat X Ma N Kundu C Ward O Goloubeva MG Johnson JC Medina TL Collins AM Fulton 2006 Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer Cancer Res 66 7701 7707 10.1158/0008-5472. CAN-06-0709 1:CAS:528:DC%2BD28XnsFyqsr4%3D 16885372 (Pubitemid 44289229)
68. T Imai K Hieshima C Haskell M Baba M Nagira M Nishimura M Kakizaki S Takagi H Nomiyama TJ Schall O Yoshie 1997 Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion Cell 91 521 530 10.1016/S0092-8674(00)80438-9 1:CAS:528:DyaK2sXnsFGltL0%3D 9390561
69. JF Bazan KB Bacon G Hardiman W Wang K Soo D Rossi DR Greaves A Zlotnik TJ Schall 1997 A new class of membrane-bound chemokine with a CX3C motif Nature 385 640 644 10.1038/385640a0 1:CAS:528:DyaK2sXht1yks7w%3D 9024663 (Pubitemid 27087578)
70. A Ferrer J Ollila G Tobin B Nagy U Thunberg Y Aalto M Vihinen J Vilpo R Rosenquist S Knuutila 2004 Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia Cancer Genet Cytogenet 153 69 72 10.1016/j.cancergencyto.2003.12.016 1:CAS:528: DC%2BD2cXmvFWlur0%3D 15325098 (Pubitemid 39592133)
71. U Andreasson S Ek H Merz R Rosenquist N Andersen M Jerkeman M Dictor CA Borrebaeck 2008 B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule Cancer Lett 259 138 145 10.1016/j.canlet.2007.10.031 1:CAS:528:DC%2BD2sXhsVCgtL3O 18060687 (Pubitemid 350251646)
72. A Inoue H Hasegawa M Kohno MR Ito M Terada T Imai O Yoshie M Nose S Fujita 2005 Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice Arthritis Rheum 52 1522 1533 10.1002/art.21007 1:CAS:528:DC%2BD2MXkvFCisro%3D 15880599 (Pubitemid 40663944)
73. WJ Streit CN Davis JK Harrison 2005 Role of fractalkine (CX3CL1) in regulating neuron-microglia interactions: development of viral-based CX3CR1 antagonists Curr Alzheimer Res 2 187 189 10.2174/1567205053585765 1:CAS:528:DC%2BD2MXltVant74%3D 15974917 (Pubitemid 40862880)
74. O D'Orlando G Gri G Cattaruzzi S Merluzzi E Betto V Gattei C Pucillo 2007 Outside inside signalling in CD40-mediated B cell activation J Biol Regul Homeost Agents 21 49 62 18261257
75. U Schonbeck P Libby 2001 The CD40/CD154 receptor/ligand dyad Cell Mol Life Sci 58 4 43 10.1007/PL00000776 1:CAS:528:DC%2BD3MXhslKgu7Y%3D 11229815
76. DN Granger T Vowinkel T Petnehazy 2004 Modulation of the inflammatory response in cardiovascular disease Hypertension 43 924 931 10.1161/01.HYP. 0000123070.31763.55 1:CAS:528:DC%2BD2cXjt1GmsbY%3D 15007038 (Pubitemid 38579889)
77. W Luczynski A Stasiak-Barmuta J Piszcz E Ilendo O Kowalczuk M Krawczuk-Rybak 2007 B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration Neoplasma 54 527 535 1:STN:280:DC%2BD2snislahtA%3D%3D 17949237
78. P Ghia P Circosta C Scielzo A Vallario A Camporeale L Granziero F Caligaris-Cappio 2005 Differential effects on CLL cell survival exerted by different microenvironmental elements Curr Top Microbiol Immunol 294 135 145 10.1007/3-540-29933-5-8 1:CAS:528:DC%2BD2MXhtlamsr%2FF 16323430
79. JA Burger MP Quiroga E Hartmann A Burkle WG Wierda MJ Keating A Rosenwald 2009 High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation Blood 113 3050 3058 10.1182/blood-2008-07-170415 1:CAS:528:DC%2BD1MXktFWntrg%3D 19074730
80. S Deaglio T Vaisitti S Aydin E Ferrero F Malavasi 2006 In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia Blood 108 1135 1144 10.1182/blood-2006-01-013003 1:CAS:528:DC%2BD28Xot1ymtL4%3D 16621959 (Pubitemid 44232007)
81. A Elhabazi A Marie-Cardine I Chabbert-de Ponnat A Bensussan L Boumsell 2003 Structure and function of the immune semaphorin CD100/SEMA4D Crit Rev Immunol 23 65 81 10.1615/CritRevImmunol.v23.i12.40 1:CAS:528: DC%2BD3sXmsVelur0%3D 12906260 (Pubitemid 36875474)
82. A Kumanogoh H Kikutani 2003 Roles of the semaphorin family in immune regulation Adv Immunol 81 173 198 10.1016/S0065-2776(03)81005-2 1:CAS:528:DC%2BD2cXhvFaqsrg%3D 14711056 (Pubitemid 38016183)